Episode description:
China has become an increasingly important part of global clinical development, with sponsors considering the region earlier than ever before as part of their broader development strategies.
In this episode, Meredith Landry, Managing Editor of Citeline’s Custom Content, speaks with Catherine Xu, Associate Director Operational Strategy at Novotech, about the factors reshaping China’s role in global clinical development. Drawing on her extensive experience supporting international clinical programmes, Catherine shares insights into the changing perceptions of China, the evolving regulatory landscape, and what sponsors should consider when planning global development strategies.
In this conversation, they explore:
- Why more sponsors are rethinking China’s role in global clinical development
- The opportunities and misconceptions shaping today’s development strategies
- Why China is attracting greater interest for Phase I and first-in-human studies
- How China’s role in global clinical development could evolve over the coming years